Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis.

Journal: Scientific reports
Published Date:

Abstract

Pathologists face a substantial increase in workload and complexity of histopathologic cancer diagnosis due to the advent of personalized medicine. Therefore, diagnostic protocols have to focus equally on efficiency and accuracy. In this paper we introduce 'deep learning' as a technique to improve the objectivity and efficiency of histopathologic slide analysis. Through two examples, prostate cancer identification in biopsy specimens and breast cancer metastasis detection in sentinel lymph nodes, we show the potential of this new methodology to reduce the workload for pathologists, while at the same time increasing objectivity of diagnoses. We found that all slides containing prostate cancer and micro- and macro-metastases of breast cancer could be identified automatically while 30-40% of the slides containing benign and normal tissue could be excluded without the use of any additional immunohistochemical markers or human intervention. We conclude that 'deep learning' holds great promise to improve the efficacy of prostate cancer diagnosis and breast cancer staging.

Authors

  • Geert Litjens
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Clara I Sanchez
  • Nadya Timofeeva
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Meyke Hermsen
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Iris Nagtegaal
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Iringo Kovacs
    Department of Pathology, Amphia Breda Medical Center, The Netherlands.
  • Christina Hulsbergen-van de Kaa
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Peter Bult
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bram van Ginneken
    Diagnostic Image Analysis Group, Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Fraunhofer Mevis, Bremen, Germany.
  • Jeroen van der Laak
    Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.